PTIX 0.96 (-8.57%)
US74365N1037BiotechnologyBiotechnology

Protagenic Therapeutics (PTIX) Stock Highlights

0.96 | -8.57%
2024-06-11 05:53:13
Protagenic Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. It provides treatments for mood, anxiety, depression and neurodegenerative disorders by using peptide-based and brain active therapeutics. The companys lead compound, PT00114, is a synthetic form of Teneurin Carboxy-terminal Associated Peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. It has also created a portfolio of novel neuropeptides that are in various stages of development and preclinical evaluation for the treatment of mood disorders.

Statistics

Range Today
0.95 1.05
Volume Today 6.5K
Range 1 Year
0.68 2.22
Volume 1 Year 2.63M
Range 3 Year
0.68 16.76
Volume 3 Year 33.66M
Range 10 Year
0.68 19.56
Volume 10 Year 87.28M

Highlights

Market Capitalization 4.66M (micro)
Floating Shares 3.22M
Current Price 0.96
Price To Earnings -0.81
Price To Book 2.18
Earnings Per Share -1.37
Payout Ratio 0%

Performance

Latest -8.57%
1 Month -27.27%
3 Months -15.04%
6 Months +14.29%
1 Year -44.19%
3 Years -90.04%
5 Years -92.23%
10 Years -92.23%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.